ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Envision Pharma, INC.

Official 2024 U.S. DOL Form 5500 summary for Envision Pharma, INC. (Envision Pharma, INC. 401(k) Plan · EIN 06-1633253 · PN 001): $92.01M net assets, 758 active participants, and $33.66 per $10,000 (33.66 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorEnvision Pharma, INC.
Filing IdentifierEnvision Pharma, INC. 401(k) Plan · EIN 06-1633253 · PN 001
Plan Category & State401(k) Defined Contribution (CT)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$92.01M
Active Participants758
Direct Admin Fee Rate$33.66 per $10,000 (33.66 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderMma Securities, LLC
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($26,224, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI